Inhibition of breast cancer growth with the combination of lapatinib and an ADAM protease inhibitor

被引：0
|
作者：
Witters, L. M.
Scherle, P. A.
Friedman, S. M.
Redman, J.
Fridman, J. S.
Caulder, E.
Lipton, A.
机构：
[1] Penn State Univ, Coll Med, Hershey, PA USA
[2] Incyte Corp, Wilmington, DE USA
来源：
BREAST CANCER RESEARCH AND TREATMENT | 2007年 / 106卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：S82 / S82
页数：1
相关论文
共 50 条
  • [31] Phase I and pharmacological trial of lapatinib in combination with gemcitabine in patients with advanced breast cancer
    R. van der Noll
    W. M. Smit
    A. N. M. Wymenga
    D. S. Boss
    M. Grob
    A. D. R. Huitema
    H. Rosing
    M. M. Tibben
    M. Keessen
    H. Rehorst
    J. H. Beijnen
    J. H. M. Schellens
    Investigational New Drugs, 2015, 33 : 1197 - 1205
  • [32] Re: Selective Inhibition of Her2-Positive Breast Cancer Cells by the HIV Protease Inhibitor Nelfinavir
    Kapoor, Shailendra
    JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2013, 105 (19): : 1515 - 1515
  • [33] LAPATINIB, A DUAL TYROSINE KINASE INHIBITOR FOR METASTATIC BREAST
    Esteve Ines, Gozalo
    Busom Montserrat, Pons
    Partearroyo Begona, Eguileor
    ATENCION FARMACEUTICA, 2009, 11 (03): : 167 - 177
  • [34] Lapatinib (Tykerb) for advanced breast cancer
    不详
    MEDICAL LETTER ON DRUGS AND THERAPEUTICS, 2007, 49 (1269): : 74 - 75
  • [35] Lapatinib for Advanced or Metastatic Breast Cancer
    Opdam, Frans L.
    Guchelaar, Henk-Jan
    Beijnen, Jos H.
    Schellens, Jan H. M.
    ONCOLOGIST, 2012, 17 (04): : 536 - 542
  • [36] Inhibition of autophagy antagonizes breast cancer brain metastogenesis and augments the anticancer activity of lapatinib
    Nawrocki, Steffan T.
    Espitia, Claudia M.
    Espinoza, Maria Janina Carrera
    Jones, Trace M.
    Gamble, Madison E.
    Sureshkumar, Sruthi
    Chang, Mengyang
    Wang, Wei
    Carew, Jennifer S.
    CLINICAL AND TRANSLATIONAL MEDICINE, 2024, 14 (04):
  • [37] Lapatinib in the treatment of breast cancer patients
    Pienkowski, Tadeusz
    ONCOLOGY IN CLINICAL PRACTICE, 2011, 7 : A7 - A11
  • [38] Anticancer Effect of Fucoidan in Combination with Tyrosine Kinase Inhibitor Lapatinib
    Oh, Byeongsang
    Kim, Jihun
    Lu, Weidong
    Rosenthal, David
    EVIDENCE-BASED COMPLEMENTARY AND ALTERNATIVE MEDICINE, 2014, 2014
  • [39] Inhibition and mechanism of action of a protease inhibitor in human pancreatic cancer cells
    Uchima, Y
    Sawada, T
    Nishihara, T
    Maeda, K
    Ohira, M
    Hirakawa, K
    PANCREAS, 2004, 29 (02) : 123 - 131
  • [40] Inhibition of the Growth of Patient-Derived Pancreatic Cancer Xenografts with the MEK Inhibitor Trametinib Is Augmented by Combined Treatment with the Epidermal Growth Factor Receptor/HER2 Inhibitor Lapatinib
    Walters, Dustin M.
    Lindberg, James M.
    Adair, Sara J.
    Newhook, Timothy E.
    Cowan, Catharine R.
    Stokes, Jayme B.
    Borgman, Cheryl A.
    Stelow, Edward B.
    Lowrey, Bryce T.
    Chopivsky, Maria E.
    Gilmer, Tona M.
    Parsons, John T.
    Bauer, Todd W.
    NEOPLASIA, 2013, 15 (02): : 143 - U207
12345